Metraipolis › archive › dc_5495aae8ead4
Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and… — Europe PMC PMID:42513436
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42513436
- DOI
- 10.3390/jcm15145521
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:20:31.726Z
- SHA-256 of the archived text
73af71ee4cb688b49bc7cb46d72cdedfa703d7ed6d808dab36b770255de3ca99- Stable URL of this page
https://metraipolis.com/documento/dc_5495aae8ead4
How to cite
Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and… — Europe PMC PMID:42513436 — Europe PMC (en), https://europepmc.org/article/MED/42513436 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5495aae8ead4 (Metraipolis archive dc_5495aae8ead4, sha256 73af71ee4cb688b49bc7cb46d72cdedfa703d7ed6d808dab36b770255de3ca99)
BibTeX
@misc{dc5495aae8ead4,
title = {Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and… — Europe PMC PMID:42513436},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42513436},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5495aae8ead4; sha256 73af71ee4cb688b49bc7cb46d72cdedfa703d7ed6d808dab36b770255de3ca99},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42513436. Agents can read the archived copy with the MCP tool read_document.